Bioequivalence Study of the Fixed-dose Combination of Saxagliptin/Metformin XR Tablets Relative to Saxagliptin (Onglyza) Tablets and Australia-sourced Diabex XR Tablets Coadministered to Healthy Subjects in the Fed State During Steady-state Administration.
Latest Information Update: 10 Feb 2012
At a glance
- Drugs Saxagliptin/metformin (Primary) ; Metformin; Saxagliptin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 17 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Jan 2012 Actual patient number 34 added as reported by ClinicalTrials.gov.
- 18 Nov 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.